Blood bank reagents and consumables

Ended Awarded Last action

Contract number
36C26021F0146
Awardee
Awarding agency
Obligated
$340,872

Award facts

Contract value 81% obligated
  • $340,872.30 Current, with exercised options
  • $418,550.03 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bedford, MA 01730, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 -$12,796
Other Administrative Action P00008 $0
Supplemental Agreement for work within scope P00007 $77,678
Other Administrative Action P00006 -$17,943
Other Administrative Action P00005 $77,678
Supplemental Agreement for work within scope P00004 -$9,478
Exercise an Option P00003 · Blood banks reagents - OY2 $77,678
Funding Only Action P00002 · DE-obligates FY21 funds. -$7,300
Exercise an Option P00001 $77,678
Original award $77,678

About this award

Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, was awarded a delivery order contract valued at $418,550.03 for blood bank reagents and consumables under the In Vitro Diagnostics, Reagents, and Test (FSS-65-VII) GSA Schedule. The contract, effective January 1, 2021, with an ultimate completion date of December 31, 2025, utilizes firm fixed-price pricing and was awarded without small business set-aside designation. This delivery order represents a call against Werfen's existing GSA Schedule vehicle, enabling the Veterans Integrated Service Network 20 to procure specialized blood bank testing supplies and reagents for the Department of Veterans Affairs' healthcare operations.

The award reflects Werfen's established position as a primary supplier of diagnostic laboratory products to the VA and other federal healthcare agencies. The company specializes in providing coagulation analyzers, blood gas analyzers, hematology testing equipment, and associated clinical laboratory consumables to support federal medical facilities. Through this and similar contract vehicles, Werfen maintains multiple blanket purchase agreements and indefinite delivery/indefinite quantity contracts across VA regional networks and other federal health agencies, positioning the company as a key provider of mission-critical diagnostic capabilities for the VA healthcare system.

Quick answers

Who was awarded contract 36C26021F0146?

36C26021F0146 was awarded to Werfen USA LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 1, 2021.

How much is contract 36C26021F0146 worth?

The government has obligated $340,872 on 36C26021F0146. Its potential value, with all options, is $418,550.

Is contract 36C26021F0146 an order under another contract?

Yes. 36C26021F0146 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C26021F0146 competed?

The extent of competition for 36C26021F0146 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award